Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
Billion Plaque Forming Units
Known as:
10^9{pfu}
, Billion PFU
, 10E9 PFU
Expand
A measure of viable infectious entities expressed in billions in the specimen or product defined as the smallest quantity that can produce a…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
ABSTRACTS 443 W05–3 Activation of p53 suppresses mitotic catastrophe in response to ionizing radiation
Keiji Suzuki
,
S. Kodama
,
+4 authors
N. Tanaka
2007
Corpus ID: 56087672
S 443 W05–3 Activation of p53 suppresses mitotic catastrophe in response to ionizing radiation Keiji SUZUKI, Seiji KODAMA, Masami…
Expand
2004
2004
Slow intravenous infusion of PV701, an oncolytic virus: Final results of a phase I study
S. Hotte
,
P. Major
,
+7 authors
R. Lorence
2004
Corpus ID: 196437912
3037 Background: PV701 is a non-recombinant, replication-competent Newcastle disease virus that targets tumor-specific defects in…
Expand
2004
2004
Slow intravenous infusion of PV701, an oncolytic virus: Final results of a phase I study.
S. Hotte
,
P. Major
,
+7 authors
R. Lorence
Journal of Clinical Oncology
2004
Corpus ID: 25466777
3037 Background: PV701 is a non-recombinant, replication-competent Newcastle disease virus that targets tumor-specific defects in…
Expand
2000
2000
Pre-Slaughter Control of Food-Borne Bacterial Pathogens in Poultry without Antibiotics
B. Hargis
,
A. Donoghue
,
S. Higgins
,
D. Donoghue
,
G. Tellez
2000
Corpus ID: 212608812
There is growing concern with regard to the continued emergence of antibiotic resistant bacteria, which pose a significant risk…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE